Most longevity clinics optimize for "peptide therapy near me" and wonder why their patient pipeline is thin. The queries that actually convert are more specific, earlier in the patient journey, and largely uncontested. Here is the full query map for peptide therapy patients across four intent stages — and what content to build for each.
Why peptide therapy patients search differently than most clinic patients
Peptide therapy patients arrive with more prior research completed than most longevity clinic patients. They are not searching because they have a new symptom — they have already diagnosed their goal and are searching for confirmation, safety information, and a trustworthy local provider. This makes them high-converting if your content meets them where they are in the process.
Three things follow from this. Informational queries have higher conversion intent than in most categories. Compound-specific content outperforms generic "peptide therapy" content. And regulatory clarity is itself a trust-building asset — patients who have been navigating a gray market want a clinic that knows the legal landscape.
Profile 1: The early researcher (curiosity stage)
These patients have heard about peptides — from a podcast, an online community, or a physician mention — and are investigating. They do not yet know which compound they want or whether they want any at all. Their queries are broad:
- "what are peptides"
- "what do peptides do"
- "are peptides safe"
- "peptides for anti-aging"
- "best peptides for recovery"
- "peptides vs steroids"
- "how do peptides work in the body"
These queries have high volume and relatively low competition for clinic-specific content. National supplement brands and biohacker media dominate them, but their content is often thin on clinical specificity. A clinic page that defines peptides clearly, explains the regulatory landscape honestly, and segments by clinical goal will outperform generic supplement content over time.
Content play: A comprehensive "What are peptides?" guide aimed at patients who are curious but not committed. Answer the foundational questions and segment by goal — recovery, longevity, body composition, gut health. End with a clear path to consultation. Email capture here has meaningful long-term conversion value; patients who discover your clinic months before they are ready to book will return to it.
Profile 2: The compound researcher (active evaluation)
These patients have identified specific compounds and are deep in research mode — reading Reddit, watching YouTube, and seeking authoritative sources that will tell them what the actual evidence says. Their queries are compound-specific and safety-focused:
- "BPC-157 mechanism of action"
- "ipamorelin side effects"
- "sermorelin vs HGH"
- "CJC-1295 half life"
- "MOTS-c research"
- "BPC-157 and TB-500 stack"
- "does ipamorelin increase IGF-1"
Content play: Individual compound pages and comparison pages that answer these questions with clinical specificity. Cite actual research by name and publication. Acknowledge what the evidence shows and where it is limited — the distinction between animal model research and human trial data matters to this patient profile. Each compound page should include a regulatory status callout so patients understand what they can access today versus what requires waiting for the PCAC process.
Profile 3: The access seeker (high intent)
These patients know what compound they want and are trying to obtain it through a legal clinical pathway. Their queries reflect this:
- "compounded BPC-157 clinic"
- "where to get sermorelin prescription"
- "ipamorelin doctor near me"
- "peptide therapy [city]"
- "longevity clinic peptides [city]"
- "is BPC-157 available from a pharmacy"
- "CJC-1295 ipamorelin prescription"
This is the highest-converting patient profile. They are ready to book. The friction between them and a consultation is almost entirely informational — they want confirmation that your clinic offers what they are looking for and that it is a legitimate clinical operation.
Content play: Local service pages targeting "[peptide name] therapy in [city]" with specific protocol information, clear physician credentials, and a frictionless booking path. These pages must confirm that your clinic operates under physician oversight with licensed compounding pharmacy sourcing. One clear call-to-action — not five options.
Profile 4: The comparison shopper (late funnel)
These patients are deciding between your clinic and alternatives — often between a local clinic and a national telehealth service, or between specific compounds. Their queries are comparative and cost-sensitive:
- "best peptide clinic [city]"
- "peptide therapy cost"
- "local peptide clinic vs online"
- "BPC-157 vs TB-500 which is better"
- "sermorelin vs ipamorelin clinic"
- "[clinic name] reviews"
- "peptide therapy price [city]"
Content play: Transparent pricing content (or clear ranges) and comparison pages that help patients understand when local clinical care is preferable to telehealth. Comparison pages targeting "[compound A] vs. [compound B]" capture the highest-intent research queries in the peptide space — the BPC-157 vs. TB-500 comparison is the single most searched peptide comparison query in wellness medicine — and naturally position your clinic as the authority before patients have decided which route to take.
The query clusters to build first
| Priority | Content cluster | Rationale |
|---|---|---|
| 1 | BPC-157 compound and regulatory content | Highest search volume; PCAC ruling will generate traffic spike; authority built now persists after ruling |
| 2 | Sermorelin service page and protocol content | Currently compoundable; can convert patients today; no regulatory caveat required |
| 3 | Ipamorelin and CJC-1295 compound pages | Removed from Category 2 in September 2024; legally compoundable now; large content gap in clinical SEO |
| 4 | BPC-157 vs. TB-500 comparison page | Most searched peptide comparison query; high AI citation potential |
| 5 | Local service pages: "[peptide] clinic [city]" | Captures access-seeker queries; differentiates from national telehealth brands |
How AI search is changing the query landscape
Approximately 30% of health-related queries now surface AI-generated answers before traditional organic results. For peptide therapy specifically, the AI search share is higher — these patients are sophisticated researchers who use ChatGPT and Perplexity as part of their investigation process.
AI search queries about peptides tend to be longer and more specific than traditional search queries: "what is the difference between sermorelin and ipamorelin for growth hormone optimization" rather than "sermorelin vs ipamorelin." Compound pages with structured, factually dense content — clear definitions, comparison tables, specific dosing and mechanism data — perform disproportionately well in AI-generated answers because AI systems extract and cite concrete, quotable information more effectively than vague benefit claims.
Frequently Asked Questions
What peptide queries have the most conversion potential?
Access-seeker queries — "[compound] doctor near me," "compounded [compound] clinic," "[compound] therapy [city]" — have the highest conversion potential because patients using them have already decided they want the treatment. Compound researcher queries have lower immediate conversion but build the patient pipeline that converts over weeks or months of follow-up.
How should clinics handle queries about compounds they cannot currently offer?
Publish educational content about Category 2 compounds like BPC-157 and TB-500 that explains the current regulatory status accurately and positions your clinic as the informed local expert. Create a waitlist or notification signup for when those compounds become legally available. Patients who trust your regulatory expertise on a compound they cannot access today will return when access opens up after the PCAC ruling.
Do peptide therapy patients actually convert from organic content?
Yes, and at higher rates than most longevity clinic content categories. Patients who find your clinic through compound-specific research content have already completed most of the consideration process. They arrive knowing what they want — they need confirmation that your clinic can provide it. Well-structured service pages with physician credentials and specific protocol information convert this audience at rates that typically exceed paid ad traffic.
How do local peptide queries differ from national telehealth queries?
Local queries — "[compound] clinic [city]," "peptide doctor near me" — signal that patients want in-person care with physician oversight. National telehealth brands compete primarily on price and convenience. Local clinics that emphasize the physician relationship, in-person monitoring, and the ability to adjust protocols based on direct assessment win the local query segment despite being unable to match telehealth brands on price or brand recognition.
How soon can clinics expect to rank for peptide queries?
Compound-specific informational queries with lower competition — "sermorelin dosing protocol," "ipamorelin half life," "CJC-1295 mechanism" — can rank within 6 to 10 weeks with quality content and basic on-page optimization. Competitive local queries — "peptide clinic [major city]" — typically take 3 to 6 months. The current pre-PCAC window is uniquely valuable because authority built now will compound into the traffic spike that follows a favorable ruling.